M. Mahdi Sleiman

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease”.

Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1717

N/A

0DataRank · unranked

11 citations

Ali Alawieh, David Bastian, Sandeepkumar Kuril, Min Dai, Anusara Daenthanasanmak +12 more

Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope

The Journal of Heart and Lung Transplantation(2021)10.1016/j.healun.2021.07.004

N/A

0DataRank · unranked

7 citations

M. Mahdi Sleiman, Xiaofeng Yang, Songqing He, Carl Atkinson, Stephen Tomlinson +1 more

In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries

Frontiers in Immunology(2021)10.3389/fimmu.2021.630581

N/A

0DataRank · unranked

7 citations

M. Mahdi Sleiman, Qi Cheng, Zhenxiao Tu, Peng Zhu, Martin Goddard +6 more